Genelux Corp (GNLX)

Aug 15, 2026

Genelux: Undervalued Oncolytic Virus Leader as Olvi-Vec Nears Key Phase 3 Ovarian Cancer Catalyst - TipRanks

Aug 15, 2026

Aug 15, 2026

Genelux (NASDAQ:GNLX) Downgraded to "Strong Sell" Rating by Wall Street Zen - marketbeat.com

Aug 15, 2026

Aug 13, 2026

Genelux Corporation Reports Second Quarter Financial Results and Provides Business Updates - Yahoo Finance

Aug 13, 2026

Aug 13, 2026

Genelux (NASDAQ:GNLX) Issues Earnings Results - marketbeat.com

Aug 13, 2026

Aug 13, 2026

Genelux (GNLX) deepens losses while funding Phase 3 cancer trial and warning on cash runway - Stock Titan

Aug 13, 2026

Aug 13, 2026

GENELUX Corp 6M 2026: Revenue $0 Net loss $(18.4M), EPS $(0.41) — 10-Q Summary - TradingView

Aug 13, 2026

Aug 12, 2026

Genelux Corp (GNLX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

Aug 12, 2026

Aug 07, 2026

Genelux Corp (GNLX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey

Aug 07, 2026

Aug 06, 2026

Insiders Sold Genelux At US$3.34, Meanwhile Stock Sits Near US$2.51 - Sahm

Aug 06, 2026

Jul 31, 2026

Genelux Corp expected to post a loss of 20 cents a shareEarnings Preview - TradingView

Jul 31, 2026

Jul 28, 2026

Genelux Corp (GNLX) Balance Sheet - TradingKey

Jul 28, 2026

Jul 27, 2026

Genelux Corp (GNLX) Cash Flow - TradingKey

Jul 27, 2026

Jul 27, 2026

Genelux Corp (GNLX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

Jul 27, 2026

Jul 26, 2026

Genelux Corp (GNLX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey

Jul 26, 2026

Jul 26, 2026

Genelux Corp (GNLX) Income Statement - TradingKey

Jul 26, 2026

Jul 25, 2026

GNLX|Genelux Corp|Price:2.890|Chg%:-0.070 - TradingKey

Jul 25, 2026

Jul 25, 2026

Genelux Corp (GNLX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey

Jul 25, 2026

Jul 24, 2026

Genelux (NASDAQ:GNLX) Shares Down 2.4%Should You Sell? - marketbeat.com

Jul 24, 2026

Jul 02, 2026

Insider Shake-Up at Genelux Corp Sparks Investor Attention - TipRanks

Jul 02, 2026

Jul 02, 2026

GENELUX (NASDAQ: GNLX) director sells 12,000 shares to cover RSU tax bill - Stock Titan

Jul 02, 2026

Jul 01, 2026

[144] GENELUX Corp SEC Filing - Stock Titan

Jul 01, 2026

Jul 01, 2026

Wall Street Analysts Are Bullish on Top Healthcare Picks - The Globe and Mail

Jul 01, 2026

Jun 30, 2026

Genelux Announces Publication of Translational Analysis Supporting Immune Activation and Chemotherapy Sensitization with Olvi‑Vec in Ovarian Cancer - The Manila Times

Jun 30, 2026

Jun 30, 2026

Genelux says Olvi-Vec may reawaken platinum response in ovarian cancer - Stock Titan

Jun 30, 2026

Jun 26, 2026

Genelux Corp. Actuals & Estimates (NASDAQ:GNLX) - TradingView

Jun 26, 2026

Jun 24, 2026

Genelux Corp (GNLX) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey

Jun 24, 2026

Jun 22, 2026

Genelux Corporation 8-K Filing: Company Details, Nasdaq Listing, and Emerging Growth Status (June 2026) - Minichart

Jun 22, 2026

Jun 22, 2026

Genelux elects director and ratifies auditor at annual shareholder meeting - Investing.com

Jun 22, 2026

Jun 22, 2026

Genelux elects director and ratifies auditor at annual shareholder meeting By Investing.com - Investing.com Nigeria

Jun 22, 2026

Jun 22, 2026

Form 8K Genelux Corp For: 22 June By Investing.com - Investing.com South Africa

Jun 22, 2026

Jun 22, 2026

Genelux (GNLX) 2026 meeting backs director John Smither and auditor - Stock Titan

Jun 22, 2026

Jun 18, 2026

Genelux (GNLX) director receives RSU and stock option grants - Stock Titan

Jun 18, 2026

Jun 18, 2026

Genelux (GNLX) director receives RSUs and stock options in new grant - Stock Titan

Jun 18, 2026

Jun 18, 2026

GENELUX (GNLX) CFO receives 278,906 restricted stock units as equity grant - Stock Titan

Jun 18, 2026

Jun 18, 2026

Genelux (NASDAQ: GNLX) grants 233,957 RSUs to General Counsel Eric Groen - Stock Titan

Jun 18, 2026

Jun 18, 2026

GENELUX (GNLX) CTO granted 174,841 RSUs under 2022 equity plan - Stock Titan

Jun 18, 2026

Jun 18, 2026

GENELUX (NASDAQ: GNLX) director James L. Tyree receives RSU and option grants - Stock Titan

Jun 18, 2026

Jun 18, 2026

Genelux (NASDAQ: GNLX) grants CEO 730,601 RSUs under 2022 plan - Stock Titan

Jun 18, 2026

Jun 18, 2026

GENELUX (GNLX) Chief Scientific Officer awarded 119,318 RSUs in equity grant - Stock Titan

Jun 18, 2026

Jun 18, 2026

GENELUX (NASDAQ: GNLX) director granted RSUs and options in new equity awards - Stock Titan

Jun 18, 2026

Jun 18, 2026

Genelux Corp (GNLX) Institutional Confidence - TradingKey

Jun 18, 2026

Jun 17, 2026

Genelux Corp (GNLX) Financial Health: Profitability & Balance Sheet Analysis - TradingKey

Jun 17, 2026

Jun 17, 2026

Genelux Corp (GNLX) Valuation: PE, PB & Fair Value Analysis - TradingKey

Jun 17, 2026

Jun 13, 2026

GNLX Q1 2026 Earnings: EPS Misses Estimates as Clinical-Stage Biotech Continues R&D FocusRevenue Warning Signal - po-news-eg.net

Jun 13, 2026

Jun 09, 2026

Genelux Corporation (GNLX) Shows Uptick: Testing Key Resistance at $3.13Float Adjusted Cap - dars.gov.et

Jun 09, 2026

Jun 05, 2026

Genelux head of regulatory Ralph Smalling sells $562 in stock By Investing.com - Investing.com India

Jun 05, 2026

Jun 04, 2026

Tax-related share sale by Genelux (GNLX) Head of Regulatory - Stock Titan

Jun 04, 2026

Jun 04, 2026

Genelux head of regulatory Ralph Smalling sells $562 in stock - Investing.com

Jun 04, 2026